Elexacaftor, Tezacaftor, Ivacaftor

DRUG2 trials

Sponsors

Meyer Children's Hospital IRCCS, Istituto Giannina Gaslini

Conditions

Cystic Fibrosis (CF)

Phase 4

Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis

Not yet recruitingNCT07809867

Istituto Giannina GasliniCystic Fibrosis (CF)

Start: 2026-09-01End: 2028-04-01Target: 50Updated: 2026-09-14

Unknown Phase

Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.

RecruitingNCT07363304

Meyer Children's Hospital IRCCSCystic Fibrosis (CF)

Start: 2025-12-02End: 2029-04-30Target: 150Updated: 2026-01-26